The Arg16Gly-β(2)-adrenoceptor single nucleotide polymorphism: exercise capacity and survival in patients with end-stage heart failure.
Leineweber, Kirsten
The Arg16Gly-β(2)-adrenoceptor single nucleotide polymorphism: exercise capacity and survival in patients with end-stage heart failure. [electronic resource] - Naunyn-Schmiedeberg's archives of pharmacology Oct 2010 - 357-65 p. digital
Publication Type: Journal Article
1432-1912
10.1007/s00210-010-0548-z doi
Blood Pressure--physiology
Disease Progression
Echocardiography
Exercise Test
Female
Genotype
Heart Failure--genetics
Heart Rate--physiology
Heart Transplantation
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Oxygen Consumption--physiology
Physical Exertion--physiology
Polymorphism, Single Nucleotide--genetics
Receptors, Adrenergic, beta-2--genetics
Treatment Outcome
The Arg16Gly-β(2)-adrenoceptor single nucleotide polymorphism: exercise capacity and survival in patients with end-stage heart failure. [electronic resource] - Naunyn-Schmiedeberg's archives of pharmacology Oct 2010 - 357-65 p. digital
Publication Type: Journal Article
1432-1912
10.1007/s00210-010-0548-z doi
Blood Pressure--physiology
Disease Progression
Echocardiography
Exercise Test
Female
Genotype
Heart Failure--genetics
Heart Rate--physiology
Heart Transplantation
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Oxygen Consumption--physiology
Physical Exertion--physiology
Polymorphism, Single Nucleotide--genetics
Receptors, Adrenergic, beta-2--genetics
Treatment Outcome